Cipla Ltd
Healthcare | Large Cap
Cipla Ltd. demonstrates a strong overall financial profile, characterized by outstanding profitability and an exceptionally stable, low-debt structure. The company's ability to generate profit from its sales and assets is a significant strength. Its reliance on owner's funds rather than borrowed money indicates a very low-risk financial position, providing a solid foundation for its operations. However, a key area of concern is the company's operational efficiency. It faces challenges in quickly converting inventory into sales and collecting payments from customers. While growth has been impressive in recent years, financial projections indicate a potential slowdown and even a decline in profits, which represents a notable future risk. Despite this, the company's capacity to cover its interest payments and dividends remains excellent, underscoring its financial stability.
Latest Report
View AllLatest News
View AllThe Latest News Is Not Available at the Moment. We’ll Notify You Once It’s Available.
- Valuation MetricsNeutral
- Market Metrics
- Stock Reports
- Stock News
- Growth Ratio7.80
- Financial Ratio8.40
- Profitability Ratio10.00
- Efficiency Ratio3.33
- Coverage Ratio9.20
- Solvency Ratio10.00
- Liquidity Ratio7.94
- Peer Assessment
- Management AssessmentStrong
- Risk AssessmentStrong
- 1 HourNeutral
- 2 HoursNeutral
- 4 HoursBearish
- 1 DayNeutral
- 1 WeekNeutral
- 1 MonthNeutral
Cipla Ltd. demonstrates a strong overall financial profile, characterized by outstanding profitability and an exceptionally stable, low-debt structure. The company's ability to generate profit from its sales and assets is a significant strength. Its reliance on owner's funds rather than borrowed money indicates a very low-risk financial position, providing a solid foundation for its operations. However, a key area of concern is the company's operational efficiency. It faces challenges in quickly converting inventory into sales and collecting payments from customers. While growth has been impressive in recent years, financial projections indicate a potential slowdown and even a decline in profits, which represents a notable future risk. Despite this, the company's capacity to cover its interest payments and dividends remains excellent, underscoring its financial stability.
Latest Report
View AllLatest News
View AllThe Latest News Is Not Available at the Moment. We’ll Notify You Once It’s Available.
Overall Valuation Score
P/E RATIO (TTM)
31.06
Industry Median
28.62
Large Cap Median
30.25
P/E RATIO
28.15
P/B RATIO
3.17
Industry Median
3.17
Large Cap Median
5.04
P/S RATIO
3.88
Industry Median
3.42
Large Cap Median
5.48
Others
PEG RATIO
2.45
EV/EBITDA RATIO
16.70
The Calculations Shown Above Are Based on the Last Traded Price (LTP) of ₹1351.8 as on Jun 21, 2026.
Unlock Live Chart
Please login to view interactive real-time technical charts powered by TradingView.
Markets Depth NSE
Buy Orders
Bid
Quantity
Orders
No buy depth
Total
0
0
Sell Orders
Ask
Quantity
Orders
No sell depth
Total
0
0
Markets Today NSE
High
0.00
Low
0.00
Open
0.00
Close
0.00
Prev Close
0.00
Avg Price
0.00
Volume
0
Last Traded Quantity
0
Last Traded Time
N/A
Price Movement Indicator
0.00
Today's Low
0.00
Today's High
Quarterly Report⬤23rd Jan 26
Quarterly Financial Results Q3 FY 2025-26
NEUTRAL SENTIMENT
Concall Report⬤30th Oct 25
Q2 FY26 Earnings Conference Call
BULLISH SENTIMENT
The company's growth profile is strong but shows signs of future volatility. It has demonstrated excellent growth in revenue, earnings per share, and its asset base in recent years. This points to successful expansion and market performance. However, a significant negative projection for operating profit and net income growth in the near future is a major concern. This suggests that while the company has been expanding, its profitability from this growth is expected to decline sharply, posing a risk to future shareholder returns.
| Growth Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue Growth Rate | 13.59 | 4.55 | 13.28 | 6.88 | 2.23 |
| Operating Profit Growth Rate | 7.08 | 10.41 | 25.14 | 13.3 | -17.47 |
| Earnings Per Share (EPS) Growth | 4.59 | 11.29 | 47.08 | 27.87 | -26.44 |
| Asset Growth Rate | 8.05 | 9.1 | 11.03 | 14.76 | 13.83 |
| Net Income Growth Rate | 6.61 | 11.23 | 46.63 | 26.84 | -26.7 |
Revenue Growth Rate
Operating Profit Growth Rate
Earnings Per Share (EPS) Growth
Asset Growth Rate
Net Income Growth Rate
The company's overall financial performance from a shareholder's perspective is strong. Key metrics such as earnings per share, both on an adjusted and cash basis, are excellent, indicating strong profitability being generated for each share. The book value and dividends per share are also growing robustly, creating value for investors. The only point of weakness is the very high level of recent and projected capital expenditures, which, while potentially driving future growth, currently represents a significant cash outlay.
| Financial Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Adjusted Earnings Per Share (Adjusted EPS) | 32.82 | 36.07 | 53.07 | 63.44 | 49.94 |
| Cash Earnings Per Share (Cash EPS) | 44.71 | 49.75 | 64.66 | 78.72 | 62.63 |
| Book Value Per Share | 258.89 | 290.77 | 331.75 | 385.11 | 425.09 |
| Dividend Per Share (DPS) | 4.99 | 8.33 | 12.76 | 16.32 | 12.97 |
| Capital Expenditures (CapEx) | 681 | 1136 | 1315 | 1515 | 3011 |
Adjusted Earnings Per Share (Adjusted EPS)
Cash Earnings Per Share (Cash EPS)
Book Value Per Share
Dividend Per Share (DPS)
Capital Expenditures (CapEx)
The company's profitability is outstanding across the board. It demonstrates an excellent ability to convert revenue into profit at every level, from gross profit down to net income. The returns it generates on the capital invested, on shareholder equity, and on its assets are all exceptional. This indicates highly effective management, strong pricing power, and efficient cost control. Despite a projected dip in 2026, the overall profitability profile is a key strength and a primary driver of the company's financial health.
| Profitability Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Gross Profit Margin | 16.09 | 16.94 | 20.33 | 21.86 | 16.59 |
| Return on Capital Employed (ROCE) | 17 | 18 | 23 | 23 | 17 |
| Return on Equity (ROE) | 12.22 | 12.1 | 15.55 | 16.89 | 11.22 |
| Return on Assets (ROA) | 16.95 | 17.16 | 19.34 | 19.09 | 13.84 |
| Operating Margin | 20.92 | 22.09 | 24.41 | 25.87 | 20.89 |
| Net Margin | 11.7 | 12.45 | 16.12 | 19.13 | 13.71 |
Gross Profit Margin
Return on Capital Employed (ROCE)
Return on Equity (ROE)
Return on Assets (ROA)
Operating Margin
Net Margin
The company's operational efficiency presents a mixed to weak picture. There are significant challenges in how effectively it uses its assets to generate revenue, as seen in its asset and capital turnover. Furthermore, the company takes a long time to sell its inventory and collect payments from customers. This ties up working capital and can impact cash flow. While its collection from customers is average for the industry, other key efficiency indicators point towards areas where operational performance is lagging.
| Efficiency Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Fixed Asset Turnover Ratio | 2.25 | 2.48 | 2.68 | 2.75 | 2.18 |
| Inventory Turnover Ratio | 3.65 | 3.6 | 3.95 | 3.96 | 3.84 |
| Receivables Turnover Ratio | 6.34 | 6.08 | 5.84 | 5.36 | 5.06 |
| Days Sales in Inventory Ratio | 100 | 101.39 | 92.41 | 92.17 | 95.05 |
| Receivable Days | 57.57 | 60.03 | 62.5 | 68.1 | 72.13 |
| Capital Turnover Ratio | 1.01 | 0.96 | 0.95 | 0.87 | 0.81 |
Fixed Asset Turnover Ratio
Inventory Turnover Ratio
Receivables Turnover Ratio
Days Sales in Inventory Ratio
Receivable Days
Capital Turnover Ratio
The company's ability to cover its financial obligations is exceptionally strong. It generates more than enough operating profit to comfortably meet its interest payments, indicating a very low risk of default on its debt. Furthermore, its earnings provide a healthy cushion to cover its dividend payments to shareholders. This robust coverage demonstrates significant financial strength and a sustainable dividend policy, which is reassuring for both creditors and investors.
| Coverage Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Interest Coverage Ratio | 33.95 | 37.71 | 64.36 | 111.02 | 97.74 |
| Equity Dividend Coverage Ratio | 6.25 | 4.17 | 4 | 4 | 3.7 |
Interest Coverage Ratio
Equity Dividend Coverage Ratio
The company exhibits an exceptionally strong solvency position, indicating a very low level of long-term financial risk. It relies minimally on debt financing, with the vast majority of its assets being funded by equity. This conservative financial structure provides a powerful defense against economic downturns and rising interest rates. The company's ability to meet its long-term obligations is not a concern, reflecting a very stable and self-reliant financial foundation.
| Solvency Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Debt Ratio | 0.03 | 0.01 | 0.01 | 0.01 | 0.01 |
| Debt to Equity Ratio | 0.03 | 0.01 | 0.01 | 0.01 | 0.01 |
| Equity Ratio | 0.97 | 0.99 | 0.99 | 0.99 | 0.99 |
| Debt To Asset Ratio | 0.02 | 0.01 | 0.01 | 0.01 | 0.01 |
Debt Ratio
Debt to Equity Ratio
Equity Ratio
Debt To Asset Ratio
The company shows a good ability to meet its short-term obligations. Its capacity to cover immediate liabilities with current assets, including and excluding inventory, is very strong. This indicates a healthy cushion to handle day-to-day operational expenses. However, its position in terms of instantly available cash is weaker, and its cash flow from core operations relative to its current debts is only moderate. This suggests that while asset-rich, the company's immediate cash availability is less robust.
| Liquidity Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Current Ratio | 2.58 | 2.74 | 2.96 | 3.08 | 2.61 |
| Quick Ratio | 1.58 | 1.82 | 2.01 | 2.11 | 1.74 |
| Cash Ratio | 0.36 | 0.28 | 0.16 | 0.14 | 0.17 |
| Operating Cash Flow Ratio | 0.62 | 0.58 | 0.75 | 0.87 | 0.52 |
Current Ratios
Quick Ratios
Cash Ratios
Operating Cash Flow Ratios
Peer Comparison empowers investors to evaluate a company against its industry peers using key financial metrics like P/E ratio, EPS, and profit margins. It helps identify whether a company is overvalued, undervalued, or performing in line with competitors. Investors can use this data to spot opportunities, assess risks, and make informed decisions. This contextual view adds depth beyond standalone company analysis.
| NO | Company Name | Health Score | P/E Ratio | Valuation | OPM | EPS | Latest Profit & Loss |
|---|---|---|---|---|---|---|---|
| 1 | Abbott India Ltd | 8.68 | 35.89 | Neutral | 1892.00 | 730.39 | 1552.00 |
| 2 | Alkem Laboratories Ltd | 8.08 | 27.91 | Neutral | 3005.00 | 182.76 | 2351.00 |
| 3 | Divis Laboratories Ltd | 7.91 | 69.71 | Highly Overvalued | 3441.00 | 98.20 | 2568.00 |
| 4 | Lupin Ltd | 7.84 | 20.16 | Neutral | 8816.00 | 139.25 | 5355.00 |
| 5 | Cipla Ltd | 7.62 | 28.15 | Neutral | 5883.00 | 43.52 | 3862.00 |
| 6 | Mankind Pharma Ltd | 7.61 | 52.10 | Highly Overvalued | 3617.00 | 49.34 | 1938.00 |
| 7 | Zydus Lifesciences Ltd | 7.60 | 21.38 | Neutral | 8475.00 | 35.38 | 5124.00 |
| 8 | Laurus Labs Ltd | 7.10 | 85.84 | Neutral | 1778.00 | 13.72 | 890.00 |
| 9 | Dr Reddys Laboratories Ltd | 6.49 | 25.31 | Neutral | 6454.00 | 38.58 | 4158.00 |
| 10 | Glenmark Pharmaceuticals Ltd | 6.36 | 45.87 | Neutral | 4572.00 | -7.12 | 1362.00 |
Cipla's management demonstrates excellent effectiveness, reflected in a robust financial turnaround and prudent capital management. Key strengths include a significant improvement in profitability metrics like OPM and ROCE, driven by operational efficiency. The balance sheet is exceptionally strong, with negligible debt and an outstanding interest coverage ratio, showcasing superior financial prudence. High and increasing institutional ownership underscores strong investor confidence in the management's strategy and execution. While long-term sales growth is moderate and the promoter holding has seen a gradual decline, these are overshadowed by the outstanding improvements in profitability and financial health.
Financial Performance & Growth
The company's financial performance is marked by a significant acceleration in profitability, although sales growth remains moderate. For the fiscal year ending March 2024, net profit grew by an impressive 48%, a substantial increase from the 10% growth in the previous year. This surge is supported by a steady improvement in operating profit margins (OPM), which have expanded from 19% in FY20 to 24% in FY24, indicating enhanced operational efficiency. However, top-line growth is less dynamic. The compounded annual sales growth over the past 10, 5, and 3 years has been modest, hovering around 7-8%. While the most recent fiscal year saw a healthier 13.28% increase in sales, the divergence between strong profit growth and moderate sales growth suggests that margin expansion has been the primary performance driver.
| Metric | 2015–2017 (Avg) | 2018–2020 (Avg) | 2021–2023 (Avg) | 2024 |
|---|---|---|---|---|
| Sales Growth (%) | 12.5% | 6.0% | 10.0% | 13.3% |
| Profit Growth (%) | -11.0% | 18.3% | 27.0% | 48.0% |
Capital Efficiency & Returns
Management has demonstrated excellent capability in improving capital efficiency. The Return on Capital Employed (ROCE) has been on a strong upward trajectory, more than doubling from 11% in FY19 to 23% in FY24. This indicates that the capital invested in the business is generating significantly higher returns. Similarly, the Return on Equity (ROE) has improved from 12% in FY23 to over 16% in FY24, delivering better returns to shareholders. The company's working capital management appears stable and efficient, with the Cash Conversion Cycle (CCC) remaining consistent at around 180-182 days in the last three years. This stability, coupled with improving inventory turnover, points to disciplined management of operating assets and liabilities.
| Metric | 2015–2017 (Avg) | 2018–2020 (Avg) | 2021–2023 (Avg) | 2024 |
|---|---|---|---|---|
| ROCE (%) | 11.7% | 10.7% | 17.3% | 23.0% |
Financial Health & Prudence
The company's financial health is outstanding, reflecting a highly prudent and conservative management approach. The most significant achievement has been the systematic reduction of debt. Total borrowings have been reduced from over ₹4,300 Cr in FY19 to just ₹559 Cr in FY24, making the company virtually debt-free. This has resulted in a negligible Debt-to-Equity ratio of 0.02. Consequently, the Interest Coverage Ratio has reached an exceptionally strong level of over 64x in FY24, meaning operating profits can cover interest expenses 64 times over. This provides an enormous safety margin. Furthermore, the company has maintained a consistent dividend payout policy, with the payout ratio standing at a healthy 25% in FY24.
| Metric | 2015–2017 (Avg) | 2018–2020 (Avg) | 2021–2023 (Avg) | 2024 |
|---|---|---|---|---|
| Borrowings (₹ Cr) | 3,673 | 3,743 | 1,291 | 559 |
| Interest Coverage Ratio (x) | 9.6 | 13.7 | 31.0 | 64.3 |
Shareholding & Ownership Structure
The ownership structure indicates strong confidence from institutional investors, though promoter holding has been declining. As of March 2024, institutional investors (FIIs and DIIs) collectively hold a majority stake of approximately 50%, with both categories showing a stable to increasing trend over the past few years. This high level of institutional ownership is a strong endorsement of the company's governance, strategy, and future prospects. On the other hand, the promoter holding has gradually decreased from over 37% in FY17 to 33.46% in FY24. While a holding of over 33% is still substantial and ensures significant alignment of interests, the persistent downward trend is a point of consideration.
| Metric | Mar 2018 | Mar 2020 | Mar 2022 | Mar 2024 |
|---|---|---|---|---|
| Promoter Holding (%) | 37.21% | 36.68% | 33.63% | 33.46% |
| FII Holding (%) | 24.18% | 17.98% | 26.65% | 25.82% |
| DII Holding (%) | 13.92% | 22.63% | 21.99% | 24.15% |
Cipla's overall risk profile is low. The company's exceptional financial health, characterized by a near-zero debt level and strong operating cash flows, provides a substantial buffer against potential business and market risks. The primary risk factors are external to its financial structure, namely a potential moderation in business growth and a gradual dilution of promoter shareholding. However, the robust balance sheet and high-quality earnings, with operating cash flow closely matching net profit, significantly mitigate the impact of these risks. The strong institutional ownership further attests to a low perceived risk from the market's perspective.
Accounting Quality
The company exhibits signs of high accounting quality. A key indicator is the strong correlation between reported profits and actual cash generation. For the fiscal year 2024, Cash Flow from Operations (CFO) was ₹4,134 Cr, which is approximately 99.5% of the reported Net Profit of ₹4,154 Cr. This near 1:1 conversion of profit into cash indicates that earnings are not just an accounting entry but are backed by real cash inflows. The CFO to Operating Profit ratio has also been consistently strong, remaining above 90% in recent years. This robust cash generation from core business activities confirms the quality of reported earnings.
0 Credits RemainingUnlock Deep Technical Insights in Seconds Only with Dhanarthi AI
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Market Sentiment
Analysis Driven By 26 Technical Indicators From The 1 Hour Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 101354.26Bearish
- SMA 201352.70Bullish
- SMA 501370.23Bearish
- EMA 101353.72Bearish
- EMA 201356.65Bearish
- EMA 501366.44Bearish
- DEMA 101352.04Bullish
- DEMA 201349.80Bullish
- DEMA 501353.59Bearish
- TEMA 101353.04Bearish
- TEMA 201350.75Bullish
- TEMA 501348.39Bullish
- MACD-4.71Bullish
- ADX14.80Weak Trend
- IndicatorValueSignal
- RSI42.56Neutral
- CCI13.65Neutral
- ROC 90.04Bullish
- ROC 140.21Bullish
- ROC 25-1.91Bearish
- Stoch K32.34Neutral
- Stoch D35.99Neutral
- IndicatorValueSignal
- BB Upper1361.79Neutral
- BB Middle1352.70Neutral
- BB Lower1343.60Neutral
- ATR7.19High Volatility
- IndicatorValueSignal
- MFI54.79Neutral
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Market Sentiment
Analysis Driven By 26 Technical Indicators From The 2 Hours Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 101352.98Bullish
- SMA 201362.79Bearish
- SMA 501377.46Bearish
- EMA 101355.26Bearish
- EMA 201361.49Bearish
- EMA 501372.94Bearish
- DEMA 101349.92Bullish
- DEMA 201350.44Bullish
- DEMA 501363.39Bearish
- TEMA 101351.33Bullish
- TEMA 201347.90Bullish
- TEMA 501349.36Bullish
- MACD-8.23Bearish
- ADX19.19Weak Trend
- IndicatorValueSignal
- RSI39.64Neutral
- CCI-55.92Neutral
- ROC 90.19Bullish
- ROC 14-1.11Bearish
- ROC 25-2.24Bearish
- Stoch K24.97Neutral
- Stoch D24.72Neutral
- IndicatorValueSignal
- BB Upper1388.79Neutral
- BB Middle1362.79Neutral
- BB Lower1336.79Neutral
- ATR9.91Low Volatility
- IndicatorValueSignal
- MFI47.51Neutral
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Market Sentiment
Analysis Driven By 26 Technical Indicators From The 4 Hours Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 101361.67Bearish
- SMA 201373.46Bearish
- SMA 501392.38Bearish
- EMA 101360.84Bearish
- EMA 201369.87Bearish
- EMA 501371.57Bearish
- DEMA 101350.51Bullish
- DEMA 201357.47Bearish
- DEMA 501391.39Bearish
- TEMA 101348.77Bullish
- TEMA 201348.44Bullish
- TEMA 50N/AN/A
- MACD-9.86Bearish
- ADX31.06Strong Trend
- IndicatorValueSignal
- RSI39.90Neutral
- CCI-115.44Oversold
- ROC 9-2.13Bearish
- ROC 14-1.64Bearish
- ROC 25-1.48Bearish
- Stoch K23.65Neutral
- Stoch D22.27Neutral
- IndicatorValueSignal
- BB Upper1404.93Neutral
- BB Middle1373.46Neutral
- BB Lower1341.99Neutral
- ATR16.36Low Volatility
- IndicatorValueSignal
- MFI23.74Neutral
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Market Sentiment
Analysis Driven By 33 Technical Indicators From The 1 Day Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 101372.67Bearish
- SMA 201386.07Bearish
- SMA 501340.48Bullish
- SMA 1001323.00Bullish
- SMA 2001423.11Bearish
- EMA 101369.83Bearish
- EMA 201373.79Bearish
- EMA 501356.66Bearish
- EMA 1001360.48Bearish
- EMA 2001395.12Bearish
- DEMA 101358.52Bearish
- DEMA 201379.08Bearish
- DEMA 501373.99Bearish
- DEMA 1001328.41Bullish
- DEMA 2001339.04Bullish
- TEMA 101350.52Bullish
- TEMA 201362.41Bearish
- TEMA 501403.56Bearish
- TEMA 1001349.26Bullish
- TEMA 2001300.31Bullish
- MACD1.09Bearish
- ADX17.10Weak Trend
- IndicatorValueSignal
- RSI43.59Neutral
- CCI-152.37Oversold
- ROC 14-2.77Bearish
- ROC 25-5.91Bearish
- Stoch K15.78Oversold
- Stoch D19.27Oversold
- IndicatorValueSignal
- BB Upper1424.80Neutral
- BB Middle1386.07Neutral
- BB Lower1347.33Neutral
- ATR26.20Low Volatility
- IndicatorValueSignal
- MFI31.87Neutral
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Market Sentiment
Analysis Driven By 21 Technical Indicators From The 1 Week Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 201322.58Bullish
- SMA 501439.55Bearish
- EMA 201361.05Bullish
- EMA 501405.10Bearish
- DEMA 201336.59Bullish
- DEMA 501357.67Bullish
- TEMA 201362.46Bullish
- TEMA 501305.12Bullish
- MACD-11.25Bullish
- ADX20.49Weak Trend
- IndicatorValueSignal
- RSI49.51Neutral
- CCI-33.22Neutral
- ROC 145.16Bullish
- ROC 25-8.42Bearish
- Stoch K83.05Overbought
- Stoch D85.05Overbought
- IndicatorValueSignal
- BB Upper1449.52Neutral
- BB Middle1322.58Neutral
- BB Lower1195.64Neutral
- ATR63.10Low Volatility
- IndicatorValueSignal
- MFI57.11Neutral
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Market Sentiment
Analysis Driven By 25 Technical Indicators From The 1 Month Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 61353.05Bullish
- SMA 121442.01Bearish
- SMA 241483.24Bearish
- EMA 61367.26Bullish
- EMA 121405.98Bearish
- EMA 241408.48Bearish
- DEMA 61327.77Bullish
- DEMA 121360.89Bullish
- DEMA 241467.33Bearish
- TEMA 61332.22Bullish
- TEMA 121310.23Bullish
- TEMA 241386.89Bullish
- MACD121.60Bearish
- ADX20.29Weak Trend
- IndicatorValueSignal
- RSI54.36Neutral
- CCI24.98Neutral
- ROC 250.07Bullish
- ROC 5037.62Bullish
- Stoch K46.90Neutral
- Stoch D66.70Neutral
- IndicatorValueSignal
- BB Upper1653.88Neutral
- BB Middle1463.18Neutral
- BB Lower1272.48Neutral
- ATR138.76High Volatility
- IndicatorValueSignal
- MFI62.33Neutral